United States · 
Who invested in Xilio Therapeutics?
Xilio Therapeutics's investors include OrbiMed, RA Capital Management, Perceptive Advisors and Bain Capital Life Sciences.
United States · Funded startup
Who invested in Xilio Therapeutics
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2026, from 1 source
- Latest round
- Round, $40MFeb 2026
- Investors
- 4
The rounds
- Feb 2026
Founders and team
From Xilio Therapeutics's own website and the SEC filings it signed: 6 on the team.
- Ben HarshbargerChief Legal Officer
- Chris FrankenfieldChief Financial and Operating Officer
- Nathan McBrideChief Information Officer
- Joseph FarmerExecutive Officeri
- Rene RussoExecutive Officer, Directori
- Timothy ClacksonExecutive Officeri
On the board, as filediAndrew HackDaniel CurranDaniel LynchDavid GardnerDavid GrayzelMichael RossPaul ClancyRachel Humphrey
Everyone who backed them
Bain Capital Life SciencesPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Xilio Therapeutics
How much has Xilio Therapeutics raised?
Xilio Therapeutics has raised $40M across 1 round since 2026.
When did Xilio Therapeutics last raise?
Xilio Therapeutics's most recent round was an Undisclosed round of $40M in Feb 2026.
What was Xilio Therapeutics's biggest round?
Its most recent round, $40M in Feb 2026, is also its largest on record.
Who backed Xilio Therapeutics first?
Xilio Therapeutics's first round on record, in Feb 2026, was backed by OrbiMed, RA Capital Management and Perceptive Advisors and 1 others.
What stage is Xilio Therapeutics at?
Xilio Therapeutics's latest named round is an Undisclosed round, in Feb 2026.
Where is Xilio Therapeutics based?
Xilio Therapeutics is based in the United States.
Companies like Xilio Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.